Ubs Group Ag Glaukos Corp Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Ubs Group Ag holds 24,806 shares of GKOS stock, worth $3.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,806

Previous 17,606 40.9%

Holding current value

$3.75 Million

Previous $2.08 Million 55.11%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $818,064 - $974,807	7,200 Added 40.9%	24,806 $3.23 Million
Q2 2024 Aug 13, 2024	SELL	$89.48 - $118.35 $1.8 Million - $2.38 Million	-20,076 Reduced 53.28%	17,606 $2.08 Million
Q1 2024 May 13, 2024	BUY	$76.4 - $96.33 $43,318 - $54,619	567 Added 1.53%	37,682 $3.55 Million
Q4 2023 Feb 09, 2024	BUY	$59.53 - $85.11 $1.79 Million - $2.57 Million	30,144 Added 432.42%	37,115 $2.95 Million
Q3 2023 Nov 09, 2023	SELL	$69.23 - $79.09 $2.33 Million - $2.66 Million	-33,669 Reduced 82.85%	6,971 $524,000
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $647,792 - $1.02 Million	14,256 Added 54.03%	40,640 $2.89 Million
Q1 2023 May 12, 2023	BUY	$43.88 - $52.48 $326,379 - $390,346	7,438 Added 39.26%	26,384 $1.32 Million
Q4 2022 Feb 08, 2023	BUY	$40.82 - $57.75 $433,141 - $612,785	10,611 Added 127.31%	18,946 $827,000
Q3 2022 Nov 10, 2022	BUY	$46.84 - $58.49 $313,828 - $391,883	6,700 Added 409.79%	8,335 $444,000
Q2 2022 Aug 10, 2022	SELL	$34.86 - $63.77 $2,161 - $3,953	-62 Reduced 3.65%	1,635 $74,000
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $534,265 - $696,846	-12,052 Reduced 87.66%	1,697 $98,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $377,611 - $534,395	-9,377 Reduced 40.55%	13,749 $611,000
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $951,018 - $1.69 Million	20,051 Added 652.07%	23,126 $1.12 Million
Q2 2021 Aug 13, 2021	SELL	$73.06 - $97.7 $1.31 Million - $1.75 Million	-17,917 Reduced 85.35%	3,075 $261,000
Q1 2021 May 12, 2021	BUY	$70.43 - $97.42 $873,261 - $1.21 Million	12,399 Added 144.29%	20,992 $1.76 Million
Q4 2020 Feb 11, 2021	BUY	$48.9 - $75.26 $343,473 - $528,626	7,024 Added 447.67%	8,593 $646,000
Q3 2020 Nov 12, 2020	BUY	$37.23 - $50.97 $3,127 - $4,281	84 Added 5.66%	1,569 $78,000
Q2 2020 Jul 31, 2020	SELL	$28.78 - $46.83 $360,670 - $586,873	-12,532 Reduced 89.41%	1,485 $57,000
Q1 2020 May 01, 2020	SELL	$25.53 - $70.14 $1.2 Million - $3.29 Million	-46,917 Reduced 77.0%	14,017 $433,000
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $854,526 - $1.04 Million	15,772 Added 34.92%	60,934 $3.32 Million
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $1.07 Million - $1.54 Million	18,298 Added 68.11%	45,162 $2.82 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $1.14 Million - $1.42 Million	17,999 Added 203.03%	26,864 $2.03 Million
Q1 2019 May 14, 2019	SELL	$50.75 - $80.54 $1.89 Million - $3.01 Million	-37,320 Reduced 80.81%	8,865 $695,000
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $1.71 Million - $2.22 Million	-32,683 Reduced 41.44%	46,185 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $401,318 - $719,594	10,525 Added 15.4%	78,868 $5.12 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $707,983 - $1.14 Million	25,633 Added 60.02%	68,343 $2.78 Million
Q1 2018 May 15, 2018	BUY	$26.05 - $34.5 $1.11 Million - $1.46 Million	42,424 Added 14833.57%	42,710 $1.32 Million
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $28,689 - $42,167	-1,171 Reduced 80.37%	286 $7,000
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $31,885 - $42,870	1,020 Added 233.41%	1,457 $48,000
Q2 2017 Aug 14, 2017	SELL	N/A	-11,118 Reduced 96.22%	437 $18,000
Q1 2017 Nov 14, 2017	BUY	N/A	11,555	11,555 $593,000

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.19B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account